Comparative proteomics profiling of a gentamicin-attenuated Leishmania infantum cell line identifies key changes in parasite thiol-redox metabolism

Journal of Proteomics

Volumn 75, Issue 5, 2012, Pages 1463-1471

  Daneshvar, Hamid ^a   Wyllie, Susan ^a   Phillips, Stephen ^a   Hagan, Paul ^b   Burchmore, Richard ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Attenuation; Leishmania; Vaccine; Virulence

Indexed keywords

GENTAMICIN; HYDROGEN PEROXIDE; PEROXIDASE; RNA BINDING PROTEIN; THIOL; TRYPANOTHIONE REDUCTASE;

ARTICLE; LEISHMANIA INFANTUM; MICROBIAL ATTENUATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARASITE VIRULENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

GENE EXPRESSION REGULATION; GENTAMICINS; HYDROGEN PEROXIDE; LEISHMANIA INFANTUM; OXIDANTS; PROTEIN SYNTHESIS INHIBITORS; PROTEOMICS; PROTOZOAN PROTEINS;

LEISHMANIA INFANTUM;

EID: 84856321253     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.018     Document Type: Article

References (34)

1. Palatnik-de-Sousa C.B., dos Santos W.R., Franca-Silva J.C., da Costa R.T., Reis A.B., Palatnik M., et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am J Trop Med Hyg Nov 2001, 65(5):510-517.
2. Daneshvar H., Coombs G.H., Hagan P., Phillips R.S. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines. J Infect Dis May 15 2003, 187(10):1662-1668.
3. Daneshvar H., Molaei M.M., Afshar R.M., Kamiabi H., Burchmore R., Hagan P., et al. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs. Vet Immunol Immunopathol May 15 2009, 129(1-2):28-35.
4. Daneshvar H., Molaei M.M., Kamiabi H., Burchmore R., Hagan P., Stephen P.R. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Parasite Immunol Nov 2010, 32(11-12):722-730.
5. Bates P.A., Tetley L. Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH. Exp Parasitol Jun 1993, 76(4):412-423.
6. Schuster F.L., Sullivan J.J. Cultivation of clinically significant hemoflagellates. Clin Microbiol Rev Jul 2002, 15(3):374-389.
7. Magnet S., Blanchard J.S. Molecular insights into aminoglycoside action and resistance. Chem Rev Feb 2005, 105(2):477-498.
8. Sundar S., Chakravarty J. Paromomycin in the treatment of leishmaniasis. Expert Opin Investig Drugs May 2008, 17(5):787-794.
9. Daneshvar H., Hagan P., Phillips R.S. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice. Parasite Immunol Nov 2003, 25(11-12):589-596.
10. Aravind L., Iyer L.M., Anantharaman V. The two faces of Alba: the evolutionary connection between proteins participating in chromatin structure and RNA metabolism. Genome Biol 2003, 4(10):R64.
11. Mikkelsen N.E., Brannvall M., Virtanen A., Kirsebom L.A. Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci U S A May 25 1999, 96(11):6155-6160.
12. Berens R.L., Brun R., Krassner S.M. A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol Jun 1976, 62(3):360-365.
13. Mallinson D.J., Coombs G.H. Biochemical characteristics of the metacyclic forms of Leishmania major and L. mexicana mexicana. Parasitology Feb 1989, 98(Pt 1):7-15.
14. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A Sep 1979, 76(9):4350-4354.
15. Welinder C., Ekblad L. Coomassie staining as loading control in Western blot analysis. J Proteome Res Mar 4 2011, 10(3):1416-1419.
16. Acestor N., Masina S., Ives A., Walker J., Saravia N.G., Fasel N. Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis. J Infect Dis Oct 15 2006, 194(8):1160-1167.
17. Cunningham M.L., Fairlamb A.H. Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem Jun 1 1995, 230(2):460-468.
18. Henderson G.B., Fairlamb A.H., Cerami A. Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei. Mol Biochem Parasitol May 1987, 24(1):39-45.
19. Tovar J., Fairlamb A.H. Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi. Nucleic Acids Res Aug 1 1996, 24(15):2942-2949.
20. Tekos A., Tsagla A., Stathopoulos C., Drainas D. Inhibition of eukaryotic ribonuclease P activity by aminoglycosides: kinetic studies. FEBS Lett Nov 17 2000, 485(1):71-75.
21. Vicens Q., Westhof E. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure Aug 2001, 9(8):647-658.
22. Vicens Q., Westhof E. RNA as a drug target: the case of aminoglycosides. Chembiochem Oct 6 2003, 4(10):1018-1023.
23. Davis B.D., Chen L.L., Tai P.C. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci U S A Aug 1986, 83(16):6164-6168.
24. Sereno D., Lemesre J.L. In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced. Antimicrob Agents Chemother Sep 1997, 41(9):1898-1903.
25. Goyal N., Roy U., Rastogi A.K. Relative resistance of promastigotes of a virulent and an avirulent strain of Leishmania donovani to hydrogen peroxide. Free Radic Biol Med 1996, 21(5):683-689.
26. Miller M.A., McGowan S.E., Gantt K.R., Champion M., Novick S.L., Andersen K.A., et al. Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J Biol Chem Oct 27 2000, 275(43):33883-33889.
27. Pearson R.D., Harcus J.L., Symes P.H., Romito R., Donowitz G.R. Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani. J Immunol Sep 1982, 129(3):1282-1286.
28. Wilson M.E., Andersen K.A., Britigan B.E. Response of Leishmania chagasi promastigotes to oxidant stress. Infect Immun Nov 1994, 62(11):5133-5141.
29. Castro H., Romao S., Gadelha F.R., Tomas A.M. Leishmania infantum: provision of reducing equivalents to the mitochondrial tryparedoxin/tryparedoxin peroxidase system. Exp Parasitol Dec 2008, 120(4):421-423.
30. Barr S.D., Gedamu L. Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi. Evidence for an enzymatic detoxification of hydroxyl radicals. J Biol Chem Sep 7 2001, 276(36):34279-34287.
31. Walker J., Acestor N., Gongora R., Quadroni M., Segura I., Fasel N., et al. Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol Feb 2006, 145(2):254-264.
32. Kima P.E., Bonilla J.A., Cho E., Ndjamen B., Canton J., Leal N., et al. Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT). PLoS Negl Trop Dis 2010, 4(10).
33. Dumas C., Ouellette M., Tovar J., Cunningham M.L., Fairlamb A.H., Tamar S., et al. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J May 15 1997, 16(10):2590-2598.
34. Sandman K., Reeve J.N. Archaeal chromatin proteins: different structures but common function?. Curr Opin Microbiol Dec 2005, 8(6):656-661.